Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07069556

ColoSense Post-Approval Study

Sponsor: Geneoscopy, Inc.

View on ClinicalTrials.gov

Summary

The post-approval study (PAS) described here will supplement existing data generated in the CRC-PREVENT clinical trial. The primary outcomes of this supplemental study will include: clinical sensitivity, clinical specificity, positive predictive value (PPV), and negative predictive value (NPV) of ColoSense.

Official title: ColoSense Post Approval Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

12500

Start Date

2025-09-05

Completion Date

2030-09-01

Last Updated

2025-11-21

Healthy Volunteers

Yes

Interventions

DEVICE

ColoSense

multi-target stool RNA test

Locations (1)

Decentralized Study

St Louis, Missouri, United States